Development of Roche in China

As an internationally renowned enterprise, the relationship between Roche and China can be traced back to more than half a century ago. As early as the 1920s, Roche set up an office in Shanghai, which opened the first chapter of Roche in China. With the vigorous development of its business in China, Roche has set up subsidiaries in Shanghai from 65438 to 0926, fully responsible for the China market until 65438 to 0950. 196 1 year, Roche returned to China. Since then, Roche's contacts with China in science, technology and business have been increasing.

After the reform and opening up, the relationship between Roche and China has been further strengthened. Through various technical exchanges, experts from Roche and China have carried out extensive technical exchanges in the fields of drugs, vitamins, medical diagnosis, flavors and fragrances, and participated in the construction of three premix cooperation projects from 1984 to 1990.

Since 1988, Roche has set up offices in Beijing, Shanghai and Guangzhou, and plans to establish a joint venture in China. From 65438 to 0994, Roche established the first joint venture in Shanghai-Shanghai Roche Pharmaceutical Co., Ltd. As the first pharmaceutical enterprise located in the national biomedical science and technology industrial base, Roche's superb scientific research and technical strength, coupled with first-class production equipment, won a wide market and reputation for its high-tech products.

In 2000, Roche registered a wholly-owned company-Roche Diagnostic Products (Shanghai) Co., Ltd. in Shanghai Waigaoqiao Free Trade Zone.

While actively investing in China, Roche does not forget to repay the society. Since 1996, Roche has donated medicines and cash worth more than 22 million yuan to the society. Roche will devote itself to the innovation of medical care and improve the quality of human life, and make due contributions to the medical care of people in China and the world.

June 5438+October 2004 10, Roche announced the establishment of a drug research and development center in Shanghai, China. This is Roche's fifth R&D center in the world, and it is also the first time Roche has set up R&D facilities in developing countries. This further demonstrates Roche's determination to develop in China for a long time.